Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation:: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour

被引:14
作者
Body, S
Asgari, K
Rickard, JF
Zhang, Z
Fone, KCF
Bradshaw, CM
Szahadi, E
机构
[1] Univ Nottingham, Queens Med Ctr, Div Psychiat, Psychopharmacol Sect, Nottingham NG7 2RD, England
[2] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England
基金
英国生物技术与生命科学研究理事会;
关键词
interval timing; free-operant psychophysical procedure; 5-HT2A receptors; 5-HT3; receptors; quipazine; m-CPBG; MDL-72222; ketanserin;
D O I
10.1007/s00213-005-2233-3
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Rationale: Temporal differentiation refers to animals' ability to regulate their behaviour during an ongoing interval. Striatal dopaminergic mechanisms are purported to be involved in temporal differentiation, and recent evidence also implicates 5-hydroxytryptaminergic (5-HTergic) mechanisms, possibly mediated by 5-HT(2)A receptors. There is evidence that 5-HT3 receptors contribute to the regulation of dopamine release in the basal ganglia; however, it is not known whether 5-HT3 receptor stimulation can influence temporal differentiation. Objective: We examined the effects of a selective 5-HT3 receptor agonist m-CPBG, a mixed 5-HT2A/3 receptor agonist quipazine, and selective 5-HT3 and 5-HT2A receptor antagonists (MDL72222 and ketanserin, respectively) on temporal differentiation in a free-operant psychophysical procedure. Methods: Twenty-four rats were trained to respond on two levers (A and 13) under a free-operant psychophysical schedule, in which sucrose reinforcement (0.6 M, 50 mu l) was provided intermittently for responding on A during the first half and on, B during the second half of 50-s trials. Logistic psychometric functions were fitted to the relative response rate data [percent responding on B (%B) vs time from trial onset (t)], and quantitative indices of timing performance [T50 (value of t corresponding to %B=50), Weber fraction, and mean time of switching from A:to B, S-50] were derived. Results: Quipazine (0.5, 1, and 2 mg kg(-1)) altered timing performance, dose-dependently reducing T50 and S50; m-CPBG (2.5, 5, and 10 mg kg(-1)) had no significant effect. The effect of quipazine was antagonized by ketanserin (2 mg kg(-1)), but not by MDL-72222 (1mg kg(-1)). Conclusions: the present results provide no evidence for the involvement of 5HT(3) receptors in temporal differentiation and indicate that the effect of quipazine on performance was mediated by 5-HT2A receptor stimulation. The results are consistent with previous evidence for the involvement of 5-HT2A receptors in interval timing behaviour.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 56 条
[1]
ALZHARANI SSA, 1996, PSYCHOPHARMACOLOGY, V127, P346
[2]
H-SCATTERING OF THIN-FILM MODES FROM PERIODIC GRATINGS OF FINITE EXTENT [J].
ANDRENKO, AS ;
NOSICH, AI .
MICROWAVE AND OPTICAL TECHNOLOGY LETTERS, 1992, 5 (07) :333-337
[3]
A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[4]
5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED [J].
BAXTER, G ;
KENNETT, G ;
BLANEY, F ;
BLACKBURN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :105-110
[5]
THE BEHAVIORAL-THEORY OF TIMING - REINFORCER RATE DETERMINES PACEMAKER RATE [J].
BIZO, LA ;
WHITE, KG .
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 1994, 61 (01) :19-33
[6]
PACEMAKER RATE IN THE BEHAVIORAL-THEORY OF TIMING [J].
BIZO, LA ;
WHITE, KG .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-ANIMAL BEHAVIOR PROCESSES, 1994, 20 (03) :308-321
[7]
BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
[8]
Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule [J].
Body, S ;
Kheramin, S ;
Ho, MY ;
Miranda, F ;
Bradshaw, CM ;
Szabadi, E .
BEHAVIOURAL PHARMACOLOGY, 2003, 14 (08) :599-607
[9]
Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats [J].
Body, S ;
Kheramin, S ;
Mobini, S ;
Ho, MY ;
Velazquez-Martinez, DN ;
Bradshaw, CM ;
Szabadi, E .
BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08) :603-614
[10]
BODY S, 2004, IN PRESS PSYCHOPHARM